Navigation Links
Aethlon Medical Releases Shareholder Letter
Date:7/14/2011

SAN DIEGO, July 14, 2011 /PRNewswire/ -- Aethlon Medical, Inc., (OTCBB: AEMD) disclosed today that its Chairman and CEO, James A. Joyce, has issued the following letter to shareholders.

(Photo:  http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b)

To our Shareholders:

Last December, I authored a shareholder letter which referenced the viewpoint of healthcare leaders who felt a need for innovative new therapeutic strategies to evolve as escalating regulatory costs, challenges and uncertainties made it nearly impossible for small to mid-size organizations to commercialize their drug candidates.  In response, we introduced the Aethlon ADAPT™ (Adaptive Dialysis-Like Affinity Platform Technology) system, as an innovative medical device platform that provides a basis to create new therapeutic devices through the convergence of affinity drug agents and plasma membrane technologies.  The Aethlon ADAPT™ system provides a previously unrecognized commercialization pathway to antibody and other affinity drug developers, who should also appreciate a less onerous medical device regulatory pathway.  We are already seeing evidence of our ADAPT™ system being the impetus for industry collaborations that offer new channels of early revenue generation.  

On May 25th, we introduced our Aethlon ADAPT™ system to the drug industry at the C21 Life Sciences Partnering Conference.  However, we had already begun to leverage our ADAPT™ system on April 1st, through a response to a government contract opportunity offered by the Defense Advanced Research Projects Agency (DARPA) entitled, "Dialysis-Like Therapeutics."  Included within our response was a proposal to develop a device that would reduce the incidence of sepsis in wounded war-fighters.  I am pleased to inform you that our submitted program was chosen for funding
'/>"/>

SOURCE Aethlon Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Aethlon Medical to Present at the 2009 RedChip Small-Cap Investor Conference on June 16, 2009
2. Aethlon Medical Announces Presentation of Hepatitis-C (HCV) Clinical Data at 42nd Annual American Society of Nephrology (ASN) Conference
3. Aethlon Medical Releases Medical Device Data Against the H1N1 Swine Flu Virus
4. Aethlon Medical Discloses Live Webcast of Todays BIOCOM Presentation
5. Aethlon Medical Announces Expansion of Hepatitis C Virus (HCV) Treatment Programs
6. Aethlon Medical Announces Approval of Hepatitis C Virus (HCV) Treatment Program
7. Aethlon Medical to Present at Rodman & Renshaw Annual Global Investment Conference
8. Aethlon Medical Reestablishes Biodefense Programs
9. Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships
10. Aethlon Medical Announces Appointment of Rod Kenley to Its Board of Directors
11. Aethlon Medical Names Rod Kenley President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... BURLINGTON, Mass. , June 18, 2013 Decision ... for pharmaceutical and healthcare issues, finds that, over the past ... ( France , Germany , ... and the United Kingdom ) have been ... most of their HIV patients, primarily to reduce costs. Additionally, ...
(Date:6/18/2013)... NEW YORK , June 18, 2013 JDRF ... ) are accelerating the development of new products that combine ... new collaboration announced today. This new, three-year commitment is an ... (T1D). Many patients with T1D not only take ... to be placed in the body for a number of ...
(Date:6/18/2013)... 2013 Today, Wall Street Reports announced ... GILD ), Health Management Associates Inc. (NYSE: HMA ... Pharmaceuticals Inc. (NASDAQ: ISIS ), and Trius Therapeutics ... of charge - including full price targets, industry analysis and ... Sciences, Inc. Research Report On June 7, 2013, ...
Breaking Medicine Technology:One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 2One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 3JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 2JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6
... announces that a new market research report is ... Urological Catheters Industry http://www.reportlinker.com/p087354/Global-Urological-Catheters-Industry.html ... worldwide markets for Urological Catheters in Thousand Units ... Dialysis Catheters (Hemodialysis, & Peritoneal), and Urinary Catheters ...
... Inc., a full service contract biomanufacturing company, today ... Development and Manufacturing Agreement with a multinational biopharmaceutical ... the process to manufacture a unique therapeutic monoclonal ... will be manufactured under cGMP conditions as a ...
Cached Medicine Technology:Reportlinker Adds Global Urological Catheters Industry 2Reportlinker Adds Global Urological Catheters Industry 3Reportlinker Adds Global Urological Catheters Industry 4Reportlinker Adds Global Urological Catheters Industry 5Reportlinker Adds Global Urological Catheters Industry 6Reportlinker Adds Global Urological Catheters Industry 7Reportlinker Adds Global Urological Catheters Industry 8Reportlinker Adds Global Urological Catheters Industry 9Reportlinker Adds Global Urological Catheters Industry 10Reportlinker Adds Global Urological Catheters Industry 11Reportlinker Adds Global Urological Catheters Industry 12Reportlinker Adds Global Urological Catheters Industry 13Reportlinker Adds Global Urological Catheters Industry 14Reportlinker Adds Global Urological Catheters Industry 15Reportlinker Adds Global Urological Catheters Industry 16Reportlinker Adds Global Urological Catheters Industry 17Reportlinker Adds Global Urological Catheters Industry 18Reportlinker Adds Global Urological Catheters Industry 19Reportlinker Adds Global Urological Catheters Industry 20Reportlinker Adds Global Urological Catheters Industry 21Reportlinker Adds Global Urological Catheters Industry 22Reportlinker Adds Global Urological Catheters Industry 23Reportlinker Adds Global Urological Catheters Industry 24Reportlinker Adds Global Urological Catheters Industry 25Reportlinker Adds Global Urological Catheters Industry 26Goodwin Biotechnology Announces Signing New Biopharmaceutical Development & Manufacturing Agreement 2
(Date:6/18/2013)... Palo Alto has taken yet another step ... with its recent major long-term solar power commitment. , ... electric power purchase agreements , which together will result in ... photovoltaic electric power per year, which is the equivalent of ... enough power to supply all 65,000+ Palo Alto residents---and then ...
(Date:6/18/2013)... 2013 Seven-year-old Riley Salz of Encino, ... He receives 40 hours a week of applied behavior ... the Center for Autism and Related Disorders (CARD). Riley ... and has experienced remarkable progress, including learning to speak, ... Riley’s personal journey through autism is now featured in ...
(Date:6/18/2013)... Hospitals Case Medical Center clinical researchers have launched ... which will evaluate the ability of a patient,s ... end stage peripheral arterial disease (PAD). , ... Surgery at University Hospitals Case Medical Center,s Harrington ... at Case Western Reserve University School of Medicine, ...
(Date:6/18/2013)... 18, 2013 More than 1.1 million people ... HIV/AIDS, according to the Centers for Disease Control and Prevention ... infected. In support of National HIV Testing Day on June ... Insurance (SSDI) representation, the CDC and other organizations are ... The CDC reports about 50,000 new HIV infections each year. ...
(Date:6/18/2013)... myCNAjobs announces the addition of new resources to ... to the Caregiver Resources Center. , As more caregivers ... baby boomers each day, the need for caregiver ... has never been greater. myCNAjobs, the fastest growing ... the first-ever free resource center for caregivers seeking professional ...
Breaking Medicine News(10 mins):Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 2Health News:Palo Alto Seals the Deal on Major Solar Electric Investments 3Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 2Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 3Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2Health News:Allsup Observes National HIV Testing Day June 27 2Health News:Allsup Observes National HIV Testing Day June 27 3Health News:myCNAjobs Adds New Resources to Growing Caregiver Career Center 2
... FAIRFAX, Va., Sept. 25 The American Society,for ... version of,its brochure Radiation Therapy for Gynecologic Cancers. ... useful information on the,different types of radiation therapy ... on the potential side effects and how to ...
... Australia have shown that positron emission tomography (PET) ... useful than mammography and ultrasound in predicting a ... patients ultimate likelihood of survival. , In research ... (ECCO 14) in Barcelona, Dr Vinod Ganju reported ...
... new song has helped scientists open a new avenue of ... there is currently no cure or even a treatment to ... in the Journal of Clinical Investigation, scientists at the University ... someday be used to treat the disease. The team used ...
... found that the breast cancer susceptibility gene, BRCA1, plays a ... can it be used to predict outcome for patients with ... tool in choosing the best therapy for them. , Dr ... 14) in Barcelona, that analysis of the expression of five ...
... gliomas (BSGs) are rare but can be very difficult ... survival rates. However, a team of Spanish researchers have ... (I/C) produced rapid clinical responses and shrank the tumours ... enrolled in a clinical trial. , Dr Jaume Mora ...
... Researchers in The Netherlands have developed a method of ... likely to have their disease recur after surgery and ... chemotherapy. , Led by Professor Rob Tollenaar at Leiden ... at The Netherlands Cancer Institute, they have analysed for ...
Cached Medicine News:Health News:Updated Brochure on Gynecologic Cancer Treatments Now Available 2Health News:PET scans can accurately detect a breast tumor's response to chemotherapy 2Health News:PET scans can accurately detect a breast tumor's response to chemotherapy 3Health News:Stem cells show promise for treating Huntington's disease 2Health News:Stem cells show promise for treating Huntington's disease 3Health News:Stem cells show promise for treating Huntington's disease 4Health News:Breast cancer susceptibility gene predicts outcome and response to treatment in lung cancer 2Health News:Breast cancer susceptibility gene predicts outcome and response to treatment in lung cancer 3Health News:New chemotherapy regimen prolongs survival in difficult-to-treat childhood brainstem gliomas 2Health News:Molecular profiling can accurately predict survival in colon cancer patients 2Health News:Molecular profiling can accurately predict survival in colon cancer patients 3
... The Clariflex® Intraocular Lens is indicated ... years of age or older in whom ... IOL is a third-generation IOL design made ... is designed both to reduce internal reflections ...
... Lenses: The Bausch & Lomb PMMA Posterior Chamber ... primary implantation for the visual correction of aphakia ... where a cataractous lens has been removed by ... be placed in the ciliary sulcus or capsular ...
... USIOL lenses are manufactured using ... processes. Perspex CQ UV PMMA ... multi-piece and single piece lenses. ... in both nonphaco and phaco ...
... II is a sterile nonpyrogenic, transparent viscoelastic ... II contains 12 mg/ml of high molecular ... hyaluronate dissolved in physiological saline. In the ... is 105,000 cps (105 Pa s) at ...
Medicine Products: